Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2017-04-26 Annual Report
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Annual Report 2016
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2016' and contains detailed sections typical of an annual report, including Corporate Information, Financial Highlights, Chairman's Statement, Management Discussion and Analysis, Directors and Senior Management, Corporate Governance Report, Environmental, Social and Governance Report, Directors' Report, Independent Auditor's Report, and comprehensive financial statements such as Consolidated Statement of Profit or Loss, Statement of Financial Position, and Notes to the Financial Statements. The content covers the full fiscal year ended 31 December 2016, with extensive financial data and narrative analysis. The document length is 15,000 characters, indicating a full report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2016
2017-04-26 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management discussion. The document is substantive and detailed, not a brief announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-03-31 English
List of Directors and their Role and Function
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including details about board committees such as the Audit Committee, Nomination Committee, and Remuneration Committee. It does not contain financial data, earnings, or report content but focuses on board composition and governance structure. This matches the description of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management. The document is short and purely informational about board members, not a full report or announcement of voting results or remuneration details. Therefore, the appropriate classification is MANG.
2017-03-30 English
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE OF AUDIT COMMITTEE AND REMUNERATION COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding changes in the company's board of directors and committee memberships. It details the resignation of a non-executive director and the appointment of a new non-executive director, including their roles in the Audit Committee and Remuneration Committee. There is no financial data, earnings information, or report content. The document is clearly about management changes, specifically board and committee membership updates. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 5,494 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Hence, the classification is MANG with high confidence.
2017-03-30 English
PRELIMINARY ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
Annual Report Classification · 100% confidence The document is a detailed financial report presenting audited consolidated annual results for the year ended 31 December 2016. It includes comprehensive financial statements such as the consolidated statement of profit or loss, statement of financial position, notes on accounting policies, adoption of new accounting standards, and auditor's review comments. The presence of full financial data, detailed notes, and the annual period covered clearly indicate this is a full Annual Report or equivalent annual financial disclosure. The document is not a brief announcement or a certification letter but contains substantive financial data and analysis for the full fiscal year. Therefore, it fits the definition of an Annual Report (10-K). FY 2016
2017-03-30 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company stating the date of a board meeting to consider and approve the final results for the year ended 31 December 2016 and the payment of a final dividend. It does not contain any financial data or detailed report content itself. The length is only 1508 characters, which is quite short and typical for an announcement rather than a full report. The document explicitly states it is an announcement of the meeting date and agenda, not the report or results themselves. Therefore, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming board meeting and results announcement, rather than the Annual Report (10-K) or Earnings Release (ER) itself.
2017-03-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.